Stock Events

Stock Events

Moberg Pharma AB 

€1.03
0
-€0.03-3.21% Tuesday 06:15

Statistics

Day High
1.03
Day Low
1.03
52W High
1.14
52W Low
0.68
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12MayExpected
Q4 2025
Next
-0.01
0.32
0.66
0.99
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MB8.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson operates in the pharmaceuticals sector, offering a wide range of healthcare products that compete with Moberg Pharma's offerings.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is a global biopharmaceutical company with a portfolio that includes treatments in areas similar to those targeted by Moberg Pharma.
Novartis
NVS
Mkt Cap279.67B
Novartis is a multinational pharmaceutical company that produces drugs in many of the same categories as Moberg Pharma.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline is a healthcare company that develops and markets drugs and vaccines in various areas, including those competing with Moberg Pharma.
Merck
MRK
Mkt Cap277.02B
Merck & Co., Inc. is a global healthcare company that offers products in areas that overlap with Moberg Pharma's therapeutic focus.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie is a biopharmaceutical company with a broad range of medical products that compete in the same market as Moberg Pharma.
Sanofi
SNY
Mkt Cap110.4B
Sanofi is a global healthcare leader that offers drugs in many of the same therapeutic areas as Moberg Pharma.
AMGEN
AMGN
Mkt Cap178B
Amgen is a biotechnology company focused on developing novel treatments, some of which compete with Moberg Pharma's products.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.7B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing directly in some of the markets targeted by Moberg Pharma.

About

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden.
Show more...
CEO
Dr. Jonas Ekblom Ph.D.
Employees
11
Country
Sweden
ISIN
SE0020353928

Listings

STU
DE
MB8.STU
MU
DE
MB8.MU
F
DE
MB8.F
ST
SE
MOB.ST

0 Comments

Share your thoughts

FAQ

What is Moberg Pharma AB stock price today?▼
The current price of MB8.MU is €1.03 EUR — it has decreased by -3.21% in the past 24 hours. Watch Moberg Pharma AB stock price performance more closely on the chart.
What is Moberg Pharma AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Moberg Pharma AB stocks are traded under the ticker MB8.MU.
Is Moberg Pharma AB stock price growing?▼
MB8.MU stock has fallen by -3.39% compared to the previous week, the month change is a +8.92% rise, over the last year Moberg Pharma AB has showed a +49.24% increase.
When is the next Moberg Pharma AB earnings date?▼
Moberg Pharma AB is going to release the next earnings report on May 12, 2026.
How many employees does Moberg Pharma AB have?▼
As of May 06, 2026, the company has 11 employees.
In which sector is Moberg Pharma AB located?▼
Moberg Pharma AB operates in the Other sector.
When did Moberg Pharma AB complete a stock split?▼
Moberg Pharma AB has not had any recent stock splits.
Where is Moberg Pharma AB headquartered?▼
Moberg Pharma AB is headquartered in Bromma, Sweden.